Clinical trial
Antenatal Allopurinol During Fetal Hypoxia
NCT00189007 · UMC Utrecht, Other · Unknown status
Key facts
| NCT number | NCT00189007 |
|---|---|
| Title | Antenatal Allopurinol During Fetal Hypoxia |
| Official title | Does Antenatal Allopurinol Administration Reduce Post-hypoxic-ischemic Reperfusion Damage During Fetal Hypoxia in the Newborn? |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fetal Hypoxia, Reperfusion Injury |
| Intervention type | Drug |
| Interventions | Allopurinol sodium, Mannitol |
| Enrollment | 222 |
| Start date | Oct 1, 2009 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2016 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 29, 2012 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: